Alcon ALC
NYSE ALC
$66.55 -1.88 (-2.75%)
As of: Sep 10, 2026 · 3:59 PM EDT

Alcon (ALC) Current Deferred Tax Assets (2009 - 2010)

Alcon (ALC) posted Current Deferred Tax Assets of $172.0 million for Q4 2010, down 1.71% on a QoQ basis from $175.0 million in Q3 2010, and up 6.17% year-over-year from $162.0 million in Q4 2009.

Analysis

Alcon (ALC) Current Deferred Tax Assets (2009 - 2010) Analysis & Trends

Alcon has reported Current Deferred Tax Assets for 2 years, with the latest figure at $172.0 million in Q4 2010.

  • On a quarterly basis, Current Deferred Tax Assets rose 6.17% year-over-year to $172.0 million in Q4 2010; TTM through Dec 2010 was $172.0 million, a 6.17% increase from a year earlier, with the FY2010 full-year figure at $172.0 million, up 6.17% from the prior year.
  • Current Deferred Tax Assets was $172.0 million for Q4 2010 at Alcon, down from $175.0 million in the prior quarter.
  • The five-year high for Current Deferred Tax Assets was $178.0 million in Q2 2010, with the low at $146.0 million in Q2 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Zimmer Biomet Holdings 17.73 Bn 17.32 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 172.00 Mn
Sep 30, 2010 175.00 Mn
Jun 30, 2010 178.00 Mn
Mar 31, 2010 163.00 Mn
Dec 31, 2009 162.00 Mn
Sep 30, 2009 159.00 Mn
Jun 30, 2009 146.00 Mn